nutch_noindex
CANCEL
COVID-2019 Alert

The latest information about the 2019 Novel Coronavirus, including vaccine clinics for children ages 6 months and older.

La información más reciente sobre el nuevo Coronavirus de 2019, incluidas las clínicas de vacunación para niños de 6 meses en adelante.

/nutch_noindex

Shehla Admani, MD

  • “Our skin tells us a lot about what is going on inside our bodies.”

Our skin tells us a lot about what is going on inside our bodies. By looking at a person’s skin I’m able to determine what is happening on the outside of the body and get clues about what is going on inside as well.

The most enjoyable part of my job is being a detective. A patient comes in with symptoms, and I help figure out what is causing their problem and then create a care plan to help treat it. With children you can make a really big impact on their lives. Whether it’s sunscreen or skin care, I like to help build healthy habits in children that they can carry with them through their entire lives.

The great thing about dermatology is that everything we are dealing with we can see with our eyes. Not only can I see it, but the patient can see it too. Most medical conditions take place only inside the body where the patient can’t see the progress. When things are working in dermatology, I know it and they know it. You get to really see the results with your own eyes, and that’s very rewarding.

Specialties

Dermatology

Work and Education

Professional Education

University of California at Irvine School of Medicine Registrar, Irvine, CA, 06/11/2011

Internship

University of California Irvine Dept of Internal Medicine, Orange, CA, 06/30/2012

Residency

UCSD Dermatology Residency, La Jolla, CA, 06/30/2017

Fellowship

Stanford University Pediatric Dermatology, Stanford, CA, 07/31/2018

Board Certifications

Dermatology, American Board of Dermatology

Pediatric Dermatology, American Board of Dermatology

Services

Dermatology

All Publications

Dermal Melanocytosis JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION Gomez, J., Admani, S. 2022; 14 (4): 161-162
Localized systemic contact dermatitis: The vulva as a clue to identify allergen ingestion. International journal of women's dermatology Admani, S., Maghfour, J., Jacob, S. E. 1800; 7 (5Part B): 843-844

View details for DOI 10.1016/j.ijwd.2021.02.009

View details for PubMedID 35028397

Scabies Infestation in the Pediatric Population JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION Vassantachart, J. M., Florentino, A., Admani, S. 2021; 13 (6): 301-304
Lice Infestations in the Pediatric Population JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION Vassantachart, J. M., Florentino, A., Admani, S. 2021; 13 (5): 284-287
COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION Kane, S., Admani, S. 2021; 13 (1): 5457
COVID-19 Pandemic Leading to the Accelerated Development of a Virtual Health Model for Isotretinoin. Journal of the Dermatology Nurses' Association Kane, S., Admani, S. 2020; 13 (1): 54-57

Abstract

Isotretinoin is a highly efficacious medication for the treatment of acne vulgaris; however, its prescription is subject to the strict requirements of the iPLEDGE restricted distribution program. These requirements have placed significant financial, time, and logistical burdens on patients taking the medication. The stay-at-home ordinances enacted by many states during the 2019 novel coronavirus (COVID-19) global pandemic have accelerated previous trends toward utilization of telehealth and decreased laboratory monitoring in the care of patients on isotretinoin. Recent changes to the iPLEDGE program allowing use of at-home pregnancy tests to meet monthly pregnancy test requirements during the pandemic have increased availability of testing options for patients of child-bearing potential on isotretinoin. The change to use of at-home pregnancy test monitoring as well as long-term trends toward increasing access to isotretinoin through the use of telehealth are discussed.

View details for DOI 10.1097/JDN.0000000000000595

View details for PubMedID 34191969

View details for PubMedCentralID PMC7813218

Aquagenic pruritus in an adolescent effectively managed with beta-alanine supplementation. Pediatric dermatology Friedlander, M. S., Admani, S. 2020

Abstract

Aquagenic pruritus is a rare debilitating condition, which can be idiopathic, iatrogenic, or associated with systemic disease. In idiopathic cases, treatment can be challenging as options are limited and of variable efficacy. Here, we report the case of a teenage boy with refractory idiopathic aquagenic pruritus effectively managed with administration of beta-alanine supplementation, a treatment gaining traction in lay media but not yet reported in the medical literature. This report adds to the limited options published for treatment of idiopathic aquagenic pruritus in pediatric patients.

View details for DOI 10.1111/pde.14440

View details for PubMedID 33170524

Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child. JAMA dermatology Lekwuttikarn, R., Lim, Y. H., Admani, S., Choate, K. A., Teng, J. M. 2018

View details for PubMedID 30566190

Wash-Line Dermatitis: A Diagnostic Clue. The Journal of clinical and aesthetic dermatology Jacob, S. E., Admani, S. 2018; 11 (10): 12

View details for PubMedID 30519373

DYE ALLERGY ASSOCIATED WITH CONTACT WITH HELLO KITTY LUNCH BOX. The Journal of clinical and aesthetic dermatology Jacob, S. E., Admani, S. 2018; 11 (9): 12

View details for PubMedID 30319725

Response Letter to "Contact Dermatitis Associated with Alopecia and Hyperpigmentation". Pediatric dermatology Goldenberg, A., Admani, S., Jacob, S. E. 2017; 34 (5): 626

View details for DOI 10.1111/pde.13249

View details for PubMedID 28884898